ArticlebioRxiv : the preprint server for biology2023
Reviving immunogenic cell death upon targeting TACC3 enhances T-DM1 response in HER2-positive breast cancer.
Mustafa Emre Gedik et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.